Use of a Vibrotactile Sensory Prosthesis in Patients With Postural Imbalance and Spatial Disorientation

NCT ID: NCT00146952

Last Updated: 2016-11-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-01-31

Study Completion Date

2007-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators propose to explore the hypothesis that vibrotactile channels for indicating spatial orientation can be exploited as a sensory prosthesis. The specific research applications will be used for guiding visual orientation, to provide alternative feedback to vision and vestibular signals for controlling balance, and for directional and lateralisation cueing in patients with neglect syndromes. The programme will study whether vibrotactile feedback improves performance and also if it speeds rehabilitation when used as an adjunct to conventional therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vestibular Diseases Peripheral Neuropathies Proprioceptive Disorders Hemispatial Neglect

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Hemineglects

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vibrotactile feedback

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sensory impairments
* Unsteadiness

Exclusion Criteria

* High strokes
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical Research Council

OTHER_GOV

Sponsor Role collaborator

Imperial College London

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael A Gresty, Pr

Role: PRINCIPAL_INVESTIGATOR

Imperial College London

Adolfo M Bronstein, Pr, MD

Role: STUDY_DIRECTOR

Imperial College London

Christopher Kennard, Pr, MD

Role: STUDY_DIRECTOR

Imperial College London

Masud Husain, Dr

Role: STUDY_DIRECTOR

Imperial College London

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Charing Cross Hospital

London, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Michael A Gresty, Pr

Role: CONTACT

Phone: 020-8846

Email: [email protected]

Francois B Asseman, Dr

Role: CONTACT

Phone: 020-8383

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Michael A Gresty, Pr

Role: primary

Francois B Asseman, Dr

Role: backup

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DNMCA-PR1077

Identifier Type: -

Identifier Source: org_study_id